Salsolinol (1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline) is a compound derived from dopamine metabolism and is capable of causing dopaminergic neurodegeneration. Oxidative modification of neurofilament proteins has been implicated in the pathogenesis of neurodegenerative disorders. In this study, oxidative modification of neurofilament-L (NF-L) by salsolinol and the inhibitory effects of histidyl dipeptides on NF-L modification were investigated. When NF-L was incubated with 0.5 mM salsolinol, the aggregation of protein was increased in a time-dependent manner. We also found that the generation of hydroxyl radicals (•OH) was linear with respect to the concentrations of salsolinol as a function of incubation time. NF-L exposure to salsolinol produced losses of glutamate, lysine and proline residues. These results suggest that the aggregation of NF-L by salsolinol may be due to oxidative damage resulting from free radicals. Carnosine, histidyl dipeptide, is involved in many cellular defense processes, including free radical detoxification. 
INTRODUCTION
Salsolinol (1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline) is an endogenous catechol isoquinoline detected in human brain (1) . Previous studies have shown that salsolinol is toxic to dopaminergic neurons both in vitro and in vivo. Recent reports have been demonstrated that salsolinol induces cell death in human dopaminergic neuroblastoma SH-SY5Y cells (2) . It has also been well documented that salsolinol could cause the massive depletion of dopaminergic neurons and participate in the pathogenesis of Parkinson's disease (PD) (3) (4) (5) . Neurofilament (NF) proteins specifically expressed in neurons and axons, have emerged as promising biomarkers for neurodegeneration both experimentally and clinically in a range of neurological disorders (6) (7) (8) . NF proteins are the most abundant proteins of the nervous system, and are composed of 3 subunits, identified as light (NF-L), medium (NF-M), and heavy (NF-H), which assemble in a 6：2：1 ratio to form long macromolecular filaments (9, 10) . Dysfunction of NF subunits plays a role in many neurodegenerative disorders, usually resulting in NF accumulation, which causes disruption of axonal transport (11) . Abnormal accumulation of NFs in neurons is associated with other neurodegenerative diseases, such as Alzheimer's disease (AD) (12) and amyotrophic lateral sclerosis (ALS) (13) . Recent progress in PD research indicates that PD might be caused by protein aggregation due to aberrant protein folding or disturbed protein degradation (14) . However, the factors and mechanisms that aggregate NFs remain to be elucidated. Carnosine (β-alanyl-L-histidine) is an antioxidant molecule that can be found in the brain, muscle and other excitable tissues. Carnosine also acts as a copper chelator and is known to induce rejuvenating effects, to participate in neuroprotective actions that preserve cell survival, to suppress cell senescence, and to possess anti-cross linking properties (15, 16) . Several studies suggest that exogenously administrated carnosine has a neuroprotective effects against brain injury resulting from a variety of different causes (17) (18) (19) . Additionally, carnosine possesses a low toxicity, as demonstrated in mammalian systems, and it is found exclusively in animal tissues. These properties suggest that carnosine may be explored as potential therapeutic agent to treat human disease. Although salsolinol is associated with the pathogenesis of neurodegenerative diseases, the effects of carnosine on salsolinol-mediated NF-L modification have not yet been reported. In this study, we found that salsolinol modified NF-L and induced the generation of •OH. We also examined the protective effects of carnosine and anserine on oxidative modification of NF-L induced by salsolinol. Carnosine and anserine were shown to significantly prevent salsolinol-mediated NF-L aggregation http://bmbreports.org BMB reports and also inhibited the generation of hydroxyl radical induced by salsolinol. These results indicated that carnosine and anserine may prevent salsolinol-mediated NF-L modification via free radical scavenging.
RESULTS AND DISCUSSION
The modification of NF-L following exposure to salsolinol was examined by SDS-PAGE analysis. As shown in Fig. 1A and B, a time-dependent increase in the formation of protein aggregates was observed. When NF-L was incubated with 0.5 mM salsolinol for 6 h, most of the protein was at the top of the gel (Fig. 1A , lane 5 and 6). NF proteins specifically expressed in neuron and axons, have been implicated in a range of neurodegenerative disorders including Alzheimer disease (12) , amyotrophic lateral sclerosis (13) and Parkinson's disease (20) . The common feature in all these disorders is the slow accumulation of NF aggregates in neuronal cells accompanied by cell death. Because abnormal accumulation of NFs is closely associated with neurodegenerative disorders, the aggregation of NF proteins might have pathological significance. In neurodegenerative disorder, the toxicity of salsolinol may be augmented by its free radical-generating function. A previous study found that salsolinol increased the production of reactive oxygen species (ROS) and significantly decreased glutathione levels in SH-SY5Y cells (21) . It has been reported that salsolinol in conjugation with the cupric ion or ferric ion undergoes redox cycling to generate ROS such as hydroxyl radicals (•OH) which cause DNA strand scission and cell death (22, 23) . The •OH can be detected using the classical method of measuring the amount of thiobarbituric acid reactive substance (TBARS) formed by •OH-mediated 2-deoxy-D-ribose degradation (24) . During the autooxidation of salsolinol, the generation of •OH was measured the level of TBARS. When salsolinol was incubated with 2-deoxy-D-ribose, the TBARS level increased in a salsolinol concentration-and time-dependent manner (Fig. 1C) . It was recently hypothesized that NF-L is involved in several neurological disorders and our data provide indirect support for this assertion (8) .
To determine the salsolinol target site on the NF-L, NF-L that had been reacted with salsolinol was evaluated by amino acid analysis following acid and alkaline hydrolysis of the modified proteins. When NF-L was reacted with 1 mM salsolinol for 6 h at 37 o C, glutamate, proline and lysine residues were found to be particularly sensitive to oxidation by salsolinol. As shown in Fig. http ://bmbreports.org 2, 9 of 125 glutamate residues (7.2%), 2 of 9 proline residues (22.2%) and 6 of 38 lysine residues (15.8%) were lost. It has been reported that ROS-dependent protein modifications lead to a loss of lysine residues. The lysine residues could reflect the formation of Schiff bases by direct reaction of the lysine amino group with ROS (25). Thus, lysine modification was the major cause for salsolinol-mediated NF-L aggregation. NFs are important cytoskeletal filaments that are expressed almost exclusively in neuronal cells. They are assembled from 3 distinct molecular mass proteins: light NF (NF-L; 66 kDa), medium NF (NF-M; 95-100 kDa) and heavy NF (NF-H; 110-115 kDa) (26, 27) , which have similar structural domains, namely, a non-α-helical amino-terminal (head) domain, a central α-helical rod domain and a carboxyl-terminal (tail) domains. It has been reported that in sequence analysis, the carboxyl-terminal tail domain of NF-L revealed 47 glutamate within 106 residues (28). The extreme charge density, particularly rich in glutamate, could provide scaffolds suitable for interaction with other cellular components, including ions or certain cytoplasmic proteins. Thus salsolinol-mediated NF-L modification would disrupt the proper function of NFs. Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy affecting motor and sensory nerves of the peripheral nervous system (29) . In CMT, disruption of assembly and aggregation of NF-L occur from mutations of NF-L (30, 31) . Recently, it was reported that CMT mutations of NF-L and small heat-shock protein B1 have similar disruptive effects on the NF network, leading to aggregation of NF-L protein with progressive degeneration and loss of viability of motor neurons (32) . Another study has shown that Pro22 CMT mutation induced abnormal filament aggregates by disrupting proper oligomer formation (33) . Our results also suggest that the modification at proline residues is the primary cause for the abnormal filament assembly of NF-L. Previous in vitro and in vivo studies have shown that carnosine possesses antioxidant properties, cytosolic buffering functions, metal chelating capabilities and may function as a wound healing agent (34) (35) (36) (37) . In this study, we found that carnosine and anserine significantly inhibited NF-L aggregation induced by salsolinol (Fig. 3) . Recently, carnosine has been shown to protect cultured neurons from oxygen glucose deprivation and to exhibit neuroprotective properties in animal models of global and cerebral ischemia (17, 38, 39) . Therefore, our data suggest that carnosine and anserine may be attractive candidate for treatment of neurodegenerative disorders. When salsolinol was incubated with NF-L in the presence of carnosine and anserine, both compounds effectively inhibited the formation of •OH (Fig.  4) . It has been reported that carnosine and related compounds quench 50-95% of •OH produced in the Fenton reaction (40) . One of the mechanisms by which antioxidants can protect their biological targets from oxidative stress is the scavenging of free http://bmbreports.org BMB reports 
radicals.
In summary, the present study suggests that NF-L was modified by salsolinol and this process involved free radical generation. We also found that carnosine and anserine are very effective in protecting against NF-L modification induced by salsolinol. Our study will be helpful to further assess carnosine and related compounds as therapeutic agents for patients with neurodegenerative diseases such as AD, ALS and PD.
MATERIALS AND METHODS

Materials
Salsolinol, thiobarbituric acid (TBA), carnosine and anserine were purchased from Sigma (St. Louis, MO, USA). Chelex 100 resin (sodium form) was obtained from Bio-Rad (Hercules, CA, USA). All solutions were treated with Chelex 100 resin to remove traces of transition metal ions.
Expression and purification of NF-L
A full-length cDNA clone of mouse NF-L in a pET-3d vector, a generous gift from Dr. Beckman (University of Alabama) was transformed into E.coli (BL21). Protein expression was performed as previously described (41) . Bacteria were grown in Luria broth supplemented with 1 mM isopropyl β-D-thiogalactopyranoside beginning at an OD 600 nm reading of 0.8. Incubation was at The pellets containing the aggregated NF-L proteins were washed twice with standard buffer before they were dissolved in urea buffer (25 mM Na-phosphate, pH 7.5, 6 M urea, 1 mM EGTA and 1 mM DDT). The sample was loaded onto a DEAE-Sepharose column and the column was washed with urea buffer. The column was eluted with a linear 25-500 mM phosphate gradient in urea buffer and 1 ml fractions of NF-L eluted between 300 and 360 mM phosphate. These fractions were pooled and either used directly or stored at -70 o C for later experiments. Protein concentration was determined by the BCA method (42) .
Oxidation of protein
Oxidative modification of NF-L (0.4 mg/ml) was carried out by incubation of the protein with salsolinol in 10 mM potassium phosphate buffer (pH 7.5) at 37 o C. After incubation of the reaction mixtures, the mixtures were then placed into Vivaspin ultrafiltration spin column (Sartoius Stedim, Goettingen, Germany), centrifuged at 13,000 rpm for 1 h and then washed with Chelex 100 treated water and centrifuged for 1 h at same speed. This was repeated four times. The filtrate was lyophilized and dissolved with phosphate buffer.
Analysis of modified protein
After treatment with various concentrations of salsolinol for various periods of time, samples of the reaction mixtures were diluted with a concentrated sample buffer (0.25 mM Tris, 40% glycerol, and 0.01% bromophenol blue). An aliquot of each sample was subjected to SDS-PAGE as described by Laemmli (43) using a 12% acrylamide slab gel. The gels were stained with 0.15% Coomassie Brilliant Blue R-250.
Measurement of hydroxyl radical (•OH)
Detection of •OH was done by measuring thiobarbituric acid reactive substance (TBARS) by a modification of the method previously described (44) . An assay mixture contained 10 mM potassium phosphate buffer (pH 7.4), 10 mM 2-deoxy-D-ribose, and various concentrations of salsolinol in a total volume of 100 μl. Reaction mixtures were incubated at 37 o C for various periods of time. The degradation of 2-deoxy-D-ribose was measured by addition of 2.8 % trichloroacetic acid (200 μl), PBS (200 μl), and 1% thiobarbituric acid (200 μl), followed by heating at 100 o C for 15 min. The samples were then cooled to room temperature and centrifuged at 15,000 rpm for 10 min. Results were read by a UV/vis spectrophotometer (Shimadzu, UV-1601) at 532 nm.
Amino acid analysis
Aliquots of modified and native NF-L preparations were hydro-http://bmbreports.org lyzed at 110 o C for 24 h after addition of 6 N HCl. Because acid hydrolysis destroys tryptophan, the tryptophan content of oxidized and native NF-L preparations was determined by means of alkaline hydrolysis as previously described (45) . The amino acid content of acid and alkaline hydrolysates was determined by HPLC separation of their phenylisothiocyanate-derivatives by using Pico-tag free amino acid analysis column and 996 photodiode array detector (Waters, Milford, MA, USA).
Statistical analysis
Values are expressed as the means ± S.D. of 3 to 5 separate experiments. The statistical differences between the means were determined by the Student t-test.
